3192 results for «365»

Filter By

3192 results

TAVI challenges: session 4

29 Nov 2022 – From PCR London Valves 2022

This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.

TAVI challenges: session 4

Mitral edge-to-edge repair: challenging cases

Watch an acute papillary muscle rupture with torrential mitral regurgitation, a transcatheter mitral edge-to-edge repair in recurrent mitral regurgitation after Alfieri stitch, and several other exciting challenging cases in this PCR LV 2022 session!

Mitral edge-to-edge repair: challenging cases

Surgical and transcatheter tricuspid intervention: state of the art - LIVE case

29 Nov 2022 – From PCR London Valves 2022

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

  • Part 1: Triscupid TEER (Live)
    A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
    They performed...
Surgical and transcatheter tricuspid intervention: state of the art

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2

Aortic stenosis and concomitant coronary artery disease

29 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to aortic stenosis and concomitant coronary artery disease to learn how and when to screen for CAD in TAVI candidates, how to optimise your procedure to facilitate future coronary access, and to discover some tips and tricks for successful coronary angiography and PCI after TAVI.

Aortic stenosis and concomitant coronary artery disease

TAVI in TAVI

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...

TAVI in TAVI

All you need to know before starting a mitral valve-in-valve or valve-in-ring procedure

29 Nov 2022 – From PCR London Valves 2022

Discover all you need to know before starting a mitral valve-in-valve or valve-in-ring procedure in this session: learn how to evaluate patients with an indication for these procedures, how to identify the risks  and determine the choice of prosthesis, the different steps of the procedure using a transseptal approach, and...

All you need to know before starting a mitral valve-in-valve or valve-in-ring procedure

Mitral valve-in-valve interventions

Discover various compelling mitral valve-in-valve interventions in this session: bioprosthetic valve dislodgment during transapical valve-in-valve-TMVR, surgical bioprosthetic valve fracture for optimising haemodynamics of mitral valve-in-valve procedure, valve-in-valve TMVR in rheumatic mitral stenosis, and more!

Mitral valve-in-valve interventions

Treatment of multi-valve disease

29 Nov 2022 – From PCR London Valves 2022

Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...

Treatment of multi-valve disease

Transcatheter tricuspid interventions: emerging evidence

29 Nov 2022 – From PCR London Valves 2022

Get insights into the latest studies regarding transcatheter tricuspid interventions with this selection of presentations on TriCLASP, bRIGHT, PASTE, EVALUATE, and more!

Transcatheter tricuspid interventions: emerging evidence

Mitral innovations

29 Nov 2022 – From PCR London Valves 2022

Discover some innovative mitral interventions with this selection of cases: transcatheter mitral edge-to-edge repair under intracardiac echocardiography only, MitraClip procedure and other structural heart interventions in augmented reality, 3D simulation to guide TMVR in a patient with prior rheumatic heart disease and aortic dissection, and more!

Mitral innovations

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

29 Nov 2022 – From PCR London Valves 2022

Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

How to achieve safe early discharge

29 Nov 2022 – From PCR London Valves 2022

Discover how to achieve safe early discharge for TAVI patients with these presentations: learn more about the need of pre-procedural planning and active post-procedural care, which ECG reading are a cause for concern, and much more!

How to achieve safe early discharge

TAVI complications: Session 4

29 Nov 2022 – From PCR London Valves 2022

With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!

TAVI complications: Session 4

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

Improving the equity of access to percutaneous valve interventions: EAPCI initiatives for patients and health care professionals

28 Nov 2022 – From PCR London Valves 2022

Consul this session if you want to understand current unmet needs in the field of transcatheter valve intervention, to appraise the impact of the Valve for Life initiative on adoption of TAVI across Europe, and to hear about the new EAPCI Core Curriculum for training in...

Improving the equity

How should I treat a calcified lesion - A patient's journey

03 Mar 2023 – From AfricaPCR 2023

In this session, follow the discussion about a 76-year-old male patient with HTN, type 2 DM, dyslipidaemia and progressive angina who presented with a preserved LVEF without RWMA and a positive treadmill exercise test... 

How should I treat a calcified lesion

TAVI for bicuspid aortic valve - LIVE case

03 Mar 2023 – From AfricaPCR 2023

Watch how this 80-year-old man with severe, symptomatic, heavily calcified bicuspid aortic stenosis, who initially presented with NSTEMI, was treated, and learn about a simplified step-by-step TAVI procedure.

Balloon valvuloplasty was performed, followed by LAD PCI with a rotablator and stent, prior to the TAVI procedure, which...

TAVI for bicuspid aortic valve

Developing STEMI networks in Africa

03 Mar 2023 – From AfricaPCR 2023

After a presentation of the Stent-Save a Life! programme, which supports the implementation of clinical practice guidelines on myocardial revascularisation, learn about the current situation of STEMI management in Africa, and more specifically in Angola, and analyze how the STEMI network could be set up in...

Developing STEMI networks in Africa

How should I treat a blue baby - A patient's journey

03 Mar 2023 – From AfricaPCR 2023

Consider the very specific case of a female newborn whose predictive diagnosis suggested two leads: newborn transient tachypnea vs neonatal sepsis, and analyze how this little patient was managed, from birth to final treatment.

How should I treat a blue baby - A patient's journey
Didn’t find what you were looking for?